-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, GBcVn5ZsbXECyGFKZAsbK7bkG7XLj0YqdQBp0tMYkPYZ1OV3l9NX+Oljl1McN68F qVVfmkBcraSot3WjQ8nfaw== 0001164710-04-000032.txt : 20040218 0001164710-04-000032.hdr.sgml : 20040218 20040218090123 ACCESSION NUMBER: 0001164710-04-000032 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20040213 FILED AS OF DATE: 20040218 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MASSEY RICHARD J CENTRAL INDEX KEY: 0000939094 STATE OF INCORPORATION: MD FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-23252 FILM NUMBER: 04611820 BUSINESS ADDRESS: STREET 1: C/O STREET 2: 16020 INDUSTRIAL DRIVE CITY: GAITHERSBURG STATE: MD ZIP: 20877 BUSINESS PHONE: 3019848000 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IGEN INTERNATIONAL INC /DE CENTRAL INDEX KEY: 0000916304 STANDARD INDUSTRIAL CLASSIFICATION: PATENT OWNERS & LESSORS [6794] IRS NUMBER: 942852543 STATE OF INCORPORATION: DE FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: 16020 INDUSTRIAL DR CITY: GAITHERSBURG STATE: MD ZIP: 20877 BUSINESS PHONE: 3019848000 MAIL ADDRESS: STREET 1: 16020 INDUSTRIAL DRIVE CITY: GAITHERSBURG STATE: MD ZIP: 20877 FORMER COMPANY: FORMER CONFORMED NAME: IGEN INC /CA/ DATE OF NAME CHANGE: 19931216 4 1 rjm-form4_ex.xml X0201 4 2004-02-13 1 0000916304 IGEN INTERNATIONAL INC /DE IGEN 0000939094 MASSEY RICHARD J 16020 INDUSTRIAL DRIVE 16020 INDUSTRIAL DRIVE GAITHERSBURG MD 20877 1 1 0 0 President & COO Common Stock 2004-02-13 4 D 0 881773 D 0 D Option to Buy 18.75 2004-02-13 4 D 0 94667 D 2000-08-01 2010-08-01 Common Stock 94667 0 D Option to Buy 37.91 2004-02-13 4 D 0 47363 D 2002-06-04 2012-06-04 Common Stock 47363 0 D Option to Buy 5.00 2004-02-13 4 D 0 60000 D 1996-05-03 2006-05-03 Common Stock 60000 0 D Option to Buy 8.75 2004-02-13 4 D 0 38572 D 1994-04-25 2004-04-25 Common Stock 38572 0 D Pursuant to Agreement and Plan of Merger ("Agreement and Plan of Merger") dated July 24, 2003 among Roche Holding Ltd, 66 Acquisition Corporation II, IGEN International, Inc. and BioVeris Corporation (formerly known as IGEN Integrated Healthcare, LLC), each share of Common Stock of IGEN International, Inc. has been converted into the right to receive cash in an amount of $47.25, without interest, plus one share of common stock of BioVeris Corporation. The Agreement is more fully described in th e Registration Statement on Form S-4 (333-109196) as filed with the Securities and Exchange Commission on January 13, 2004. This option, which provided for vesting in installments, was cancelled in the Agreement and Plan of Merger, and in accordance therewith, each share under option was exchanged for a cash payment of $9.34 (representing the difference between the exercise price of the option and $47.25 per share) plus one (1) share of common stock of BioVeris Corporation. This option, which provided for vesting in installments, was cancelled in the Agreement and Plan of Merger, and in accordance therewith, each share under option was exchanged for a cash payment of $28.50 (representing the difference between the exercise price of the option and $47.25 per share) plus one (1) share of common stock of BioVeris Corporation. This option, which provided for vesting in installments, was cancelled in the Agreement and Plan of Merger, and in accordance therewith, each share under option was exchanged for a cash payment of $42.25 (representing the difference between the exercise price of the option and $47.25 per share) plus one (1) share of common stock of BioVeris Corporation. This option, which provided for vesting in installments, was cancelled in the Agreement and Plan of Merger, and in accordance therewith, each share under option was exchanged for a cash payment of $38.50 (representing the difference between the exercise price of the option and $47.25 per share) plus one (1) share of common stock of BioVeris Corporation. /s/Richard J. Massey 2004-02-17 -----END PRIVACY-ENHANCED MESSAGE-----